News

Press Releases

November 3, 2025
Life Biosciences Appoints Industry Veteran David Guyer, M.D. to Board of Directors

August 26, 2025
Life Biosciences Presents New Data at ARDD 2025 on the Company’s Partial Epigenetic Reprogramming Platform in Liver and Ocular Diseases

July 22, 2025
Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies

January 27, 2025
Life Biosciences Appoints Dr. Michael Ringel as Chief Operating Officer

October 21, 2024
Life Biosciences Presents at AAO Highlighting Progress of Nonhuman Primate Studies Evaluating Partial Epigenetic Reprogramming to Restore Visual Function

May 23, 2023
Life Biosciences Expands Team with the Appointment of Ming Yang, Ph.D., as SVP of Research and Development

May 8, 2023
Life Biosciences and Forge Biologics Announce cGMP Manufacturing Partnership to Advance Development of Novel Gene Therapies for Aging- Related Diseases

April 23, 2023
Life Biosciences Presents Groundbreaking Data at ARVO Demonstrating Restoration of Visual Function in Nonhuman Primates

February 13, 2023
Life Biosciences Appoints Sharon Rosenzweig-Lipson, PhD as Chief Scientific Officer

February 9, 2023
Life Biosciences CEO Jerry McLaughlin to Speak at Roadmap to Healthy Longevity International Summit

April 14, 2022
Life Biosciences to Present at Longevity Leaders World Congress 2022

January 5, 2022
Life Biosciences, Leading Developer of Therapeutics for Aging-Related Diseases, Completes $82 Million Series C Financing Round

September 28, 2021
Life Biosciences Receives Translational Research Funding from Alzheimer's Drug Discovery Foundation

July 1, 2021
Life Biosciences Appoints Seasoned Biopharma Executive Jerry McLaughlin as CEO

April 22, 2021
Life Biosciences Announces Publication in Cell Demonstrating Therapeutic Benefit of Chaperone-Mediated Autophagy Activators in Alzheimer's Disease Models

April 14, 2021
Life Biosciences to Present at 5th Stanford Drug Discovery Symposium

February 18, 2021
Life Biosciences Announces Pioneering Research in Nature Describing New Mechanisms for Reversing Age-Related Disease

February 1, 2021
Life Biosciences Appoints Joan Mannick, MD, to Lead its Research and Development

May 13, 2019
Life Biosciences Strengthens Executive Leadership Team with Addition of Amit Shashank as General Counsel

March 4, 2019
Dr. Mehmood Khan Named CEO of Life Biosciences

January 15, 2019
Life Biosciences Announces Closing of $50 Million Series B Financing Round

December 4, 2018
Life Biosciences Names New Member of Board Of Directors